(Q33673754)

28 July 2017

1 reference

title

Cardiac complications in the intensive care unit (English)

1 reference

28 July 2017

1 reference

Francis GS

1

1 reference

28 July 2017

publication date

1 June 1999

1 reference

Clinics in Chest Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

20

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

269-285

1 reference

Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency. European Co-operative S

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Analysis of pacemaker malfunction and complications of temporary pacing in the coronary care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

The cardiac effects of adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Regulation of potassium channels by nonsedating antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Adenosine increases sympathetic nerve traffic in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Long QT syndrome during high-dose cisapride

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Life-threatening alterations in heart rate after the use of adenosine in atrial flutter.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Hypokalemia from Beta2-Receptor Stimulation by Circulating Epinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Hazards of intravenous verapamil for sustained ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Adenosine and supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Haemodynamic deterioration after treatment with adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Transesophageal echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Prevention and management of bleeding complications after thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Potassium/magnesium depletion in patients with cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Effects of electrical countershock on serum creatine phosphokinase (CPK) isoenzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Hypotension with ventricular pacing: an atria vasodepressor reflex in human beings

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Optimal technique for electrical cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Proarrhythmia in patients with the Wolff-Parkinson-White syndrome after standard doses of intravenous adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Electrocardiographic changes after cardioversion of ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Adenosine and its cardiovascular effects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Torsades de pointes induced by erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Nonpharmacologic management of cardiac arrest and cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical t

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Identification of comatose patients at high risk for death or severe disability. SUPPORT Investigators. Understand Prognoses and Preferences for Outcomes and Risks of Treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Clinical variables affecting recovery of left atrial mechanical function after cardioversion from atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Transesophageal echocardiography predicts mortality in critically ill patients with unexplained hypotension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Torsade de pointes and low-dose oral haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Treating menstruating women with thrombolytic therapy: Insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Myocardial infarction and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Origin of elevated serum enzyme activities after direct-current countershock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

The calamity of cardioversion of conscious patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Thromboembolism in chronic atrial flutter: is the risk underestimated?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Giant U waves and associated ventricular tachycardia complicating astemizole overdose: Successful therapy with intravenous magnesium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Cardiac electrophysiology of adenosine. Basic and clinical concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Myocardial infarction, thrombolytic therapy, and stroke. A community-based study. The MITI Project Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronar

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Safety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Torsades de pointes occurring in association with terfenadine use

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

1 reference

7 January 2021

More on Thrombolysis and Hemorrhagic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Mechanism of Adenosine-Induced Elevation of Pulmonary Capillary Wedge Pressure in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Stroke and acute Myocardial Infarction in the Thrombolytic era: Clinical correlates and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Transesophageal echocardiography in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Atrial flutter--update on the mechanism and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Erythromycin-induced cardiac toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Appraisal of electroconversion in treatment of cardiac dysrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Ibutilide and the treatment of atrial arrhythmias. A new drug--almost unheralded--is now available to US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Frequency of hypokalemia after successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

The pacemaker syndrome: old and new causes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Presenting pulse pressure predicts thrombolytic therapy-related intracranial hemorrhage. Thrombolytic Predictive Instrument (TPI) Project results

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Torsades de Pointes associated with intravenous haloperidol in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Mechanisms of adenosine-mediated actions on cellular and clinical cardiac electrophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Role of transesophageal echocardiography in hemodynamically unstable patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Effect of direct current shocks on left atrial mechanical function in patients with structural heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Adenosine-induced atrial arrhythmia: a prospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Incidence and mortality from early stroke associated with acute myocardial infarction in the prethrombolytic and thrombolytic eras. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) and Israeli Thrombolytic Survey Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Stroke after acute myocardial infarction: relation to infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Dysrhythmias after direct-current cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Magnesium deficiency: pathogenesis, prevalence, and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Mechanism of the cardiotoxic actions of terfenadine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

Cardiac actions of antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970141-6

7 January 2021

10.1016/S0272-5231(05)70141-6

Identifiers

DOI

1 reference

28 July 2017

1 reference